Cargando…
Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis
BACKGROUND: The country of Georgia has a high prevalence of tuberculosis (TB) and hepatitis C virus (HCV) infection. PURPOSE: To determine whether HCV co-infection increases the risk of incident drug-induced hepatitis among patients on first-line anti-TB drug therapy. METHODS: Prospective cohort stu...
Autores principales: | Lomtadze, Nino, Kupreishvili, Lali, Salakaia, Archil, Vashakidze, Sergo, Sharvadze, Lali, Kempker, Russell R., Magee, Matthew J., del Rio, Carlos, Blumberg, Henry M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868578/ https://www.ncbi.nlm.nih.gov/pubmed/24367617 http://dx.doi.org/10.1371/journal.pone.0083892 |
Ejemplares similares
-
Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis
por: Vashakidze, Sergo A., et al.
Publicado: (2019) -
1884. Clinical Outcomes Among Patients with Drug-Resistant Tuberculosis Receiving Bedaquiline or Delamanid Containing Regimens
por: Kempker, Russell R, et al.
Publicado: (2019) -
Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015–2020
por: Baliashvili, Davit, et al.
Publicado: (2023) -
A case report of persistent drug-sensitive pulmonary tuberculosis after treatment completion
por: Vashakidze, Sergo A., et al.
Publicado: (2022) -
HIV co-infection increases the risk of post-tuberculosis mortality among patients treated for drug resistant tuberculosis
por: Salindri, Argita D., et al.
Publicado: (2023)